Market Overview

Aclaris Therapeutics (NASDAQ: ACRS)

1.64 +0.06 (3.80%)

Analyst Ratings

DateResearch FirmActionCurrentPT
10/23/19SVB LeerinkUpgradesOutperform
10/22/19SVB LeerinkUpgradesOutperform
9/06/19JMP SecuritiesDowngradesMarket Perform
8/09/19Cantor FitzgeraldReiteratesOverweight5.0
6/27/19SVB LeerinkDowngradesMarket Perform
5/06/19SVB LeerinkInitiates Coverage OnOutperform
10/16/18JMP SecuritiesMaintainsMarket Outperform34.0
3/28/18Leerink SwannMaintainsOutperform52.0
3/13/18Leerink SwannMaintainsOutperform54.0
2/09/18GuggenheimInitiates Coverage OnBuy53.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter